Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 137

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 137
---
 hedging policy to eliminate currency exposures. However, the directors monitor the related foreign currency exposure
closely and will consider hedging significant foreign currency exposures should the need arise.

<div align='center'>80</div>

Economic and political risks

NewGenIvf’s operations
are mainly conducted in Thailand, Cambodia and Kyrgyzstan. Accordingly, NewGenIvf’s business, financial condition, and results of
operations may be influenced by changes in the political, economic, and legal environments in Thailand, Cambodia and Kyrgyzstan.

NewGenIvf’s operations
in Thailand, Cambodia and Kyrgyzstan are subject to special considerations and significant risks not typically associated with companies
in North America and Western Europe. These include risks associated with, among other things, the political, economic and legal environment
and foreign currency exchange. NewGenIvf’s results may be adversely affected by changes in the political and social conditions in
Thailand, Cambodia and Kyrgyzstan, and by changes in governmental policies with respect to laws and regulations, anti-inflationary measures,
currency conversion, remittances abroad, and rates and methods of taxation, among other things.

Travel restriction risk

International clients contribute
a large portion of NewGenIvf’s revenue. International clients need to travel to Thailand, Cambodia and Kyrgyzstan for treatment
services, where NewGenIvf’s operations are mainly conducted.

International traveling to
Thailand, Cambodia and Kyrgyzstan may be affected by a number of factors, including local and global political and economic conditions.
Furthermore, an outbreak, or threatened outbreak, of any severe contagious disease may also in turn significantly reduce the demand of
traveling or cause extensive travel restrictions. NewGenIvf’s results may be materially and adversely affected if travel restriction
was imposed or difficulties in cross-border flow arose.

Inflation risk

Management of NewGenIvf monitors
changes in prices levels. Historically inflation has not materially impacted NewGenIvf’s consolidated financial statements; however,
significant increases in the price of labor that cannot be passed to NewGenIvf’s customers could adversely impact its results of
operations.

Critical Accounting Policies, Judgments and Estimates

NewGenIvf prepares its financial
statements in conformity with U.S. GAAP, which requires NewGenIvf to make judgments, estimates and assumptions. NewGenIvf continually
evaluates these estimates and assumptions based on the most recently available information, its historical experience and various other
assumptions that NewGenIvf’s management